高雄醫學大學圖書館 |

Investigating the Consequences of Conjugated and Secreted ISG15 on Coronavirus Pathogenesis /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Investigating the Consequences of Conjugated and Secreted ISG15 on Coronavirus Pathogenesis // Mudassir Syed Ali.
作者:	Ali, Mudassir Syed,
面頁冊數:	1 electronic resource (151 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
提要註:	Coronaviruses have evolved a breadth of mechanisms to antagonize host innate immune responses. One widely studied mechanism is the ability to deconjugate ISG15 from target proteins in a process called deISGylation, which is catalyzed by the papain-like protease (PLP) domain of viral non-structural protein (nsp) 3. Since PLP activity is required for viral replication, it has been challenging to generate an infectious virus with a PLP that maintains protease activity but has lost deISGylase activity. In this study, we generated a chimeric MHV-A59 with its PLP2 domain replaced with that of the human coronavirus HKU1, which has been documented to have minimal deISGylase activity in vitro. By using this virus, we determined that the deISGylase activity is critical for inhibiting the IFN-response in primary macrophages and promoting robust viral replication. Importantly, we also report that without deISGylase activity, the chimeric virus is highly attenuated in vivo and is more rapidly cleared from infected mice compared to MHV-A59. Accordingly, we found that at earlier stages of infection, MHV-HP2 induces a higher IFN response in the liver, providing a potential mechanism for the rapid clearance of the deISGylase-deficient coronavirus. These results document the critical role of viral deISGylase activity as a key contributor to innate immune evasion during coronavirus infection.We also investigated the ability of ISG15 to be secreted from the cell in response to coronavirus infection. The mechanism of ISG15 secretion was unknown. Here, we report that ISG15 is secreted from inflammasome-activated macrophages via gasdermin D (GSDMD) pores on the plasma membrane, mirroring the unconventional secretory pathway used by IL-1β and IL-18. Secretion of ISG15 is negated by deletion of GSDMD. It is also inhibited by treatment with the small-molecule pan-caspase inhibitor zVAD-fmk, the FDA-approved drug disulfiram, the caspase-1 inhibitor VX-765, and the NLRP3 inhibitor MCC-950, all of which block GSDMD pore formation. This study paves the way for investigating how extracellular ISG15 contributes to viral pathogenesis.Finally, we interrogated the effects of extracellular ISG15 on coronavirus replication and activation of the innate immune response through the addition of recombinant ISG15 (rISG15) to macrophages. By analyzing changes in gene expression and cytokine release in BMDMs treated with rISG15 and comparing them to IFN-driven responses, we determined that extracellular ISG15 has antiviral and proinflammatory effects during MHV-infection that is distinct from the IFN response. This study contributes to our understanding of how coronavirus infection drives inflammation within the infected host.
Contained By:	Dissertations Abstracts International86-12B.
標題:	Cellular biology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31936874
ISBN:	9798315794851

Investigating the Consequences of Conjugated and Secreted ISG15 on Coronavirus Pathogenesis /
Ali, Mudassir Syed,

Investigating the Consequences of Conjugated and Secreted ISG15 on Coronavirus Pathogenesis /Mudassir Syed Ali. - 1 electronic resource (151 pages)

Source: Dissertations Abstracts International, Volume: 86-12, Section: B.

Coronaviruses have evolved a breadth of mechanisms to antagonize host innate immune responses. One widely studied mechanism is the ability to deconjugate ISG15 from target proteins in a process called deISGylation, which is catalyzed by the papain-like protease (PLP) domain of viral non-structural protein (nsp) 3. Since PLP activity is required for viral replication, it has been challenging to generate an infectious virus with a PLP that maintains protease activity but has lost deISGylase activity. In this study, we generated a chimeric MHV-A59 with its PLP2 domain replaced with that of the human coronavirus HKU1, which has been documented to have minimal deISGylase activity in vitro. By using this virus, we determined that the deISGylase activity is critical for inhibiting the IFN-response in primary macrophages and promoting robust viral replication. Importantly, we also report that without deISGylase activity, the chimeric virus is highly attenuated in vivo and is more rapidly cleared from infected mice compared to MHV-A59. Accordingly, we found that at earlier stages of infection, MHV-HP2 induces a higher IFN response in the liver, providing a potential mechanism for the rapid clearance of the deISGylase-deficient coronavirus. These results document the critical role of viral deISGylase activity as a key contributor to innate immune evasion during coronavirus infection.We also investigated the ability of ISG15 to be secreted from the cell in response to coronavirus infection. The mechanism of ISG15 secretion was unknown. Here, we report that ISG15 is secreted from inflammasome-activated macrophages via gasdermin D (GSDMD) pores on the plasma membrane, mirroring the unconventional secretory pathway used by IL-1β and IL-18. Secretion of ISG15 is negated by deletion of GSDMD. It is also inhibited by treatment with the small-molecule pan-caspase inhibitor zVAD-fmk, the FDA-approved drug disulfiram, the caspase-1 inhibitor VX-765, and the NLRP3 inhibitor MCC-950, all of which block GSDMD pore formation. This study paves the way for investigating how extracellular ISG15 contributes to viral pathogenesis.Finally, we interrogated the effects of extracellular ISG15 on coronavirus replication and activation of the innate immune response through the addition of recombinant ISG15 (rISG15) to macrophages. By analyzing changes in gene expression and cytokine release in BMDMs treated with rISG15 and comparing them to IFN-driven responses, we determined that extracellular ISG15 has antiviral and proinflammatory effects during MHV-infection that is distinct from the IFN response. This study contributes to our understanding of how coronavirus infection drives inflammation within the infected host.

English

ISBN: 9798315794851Subjects--Topical Terms:

523871
Cellular biology.
Subjects--Index Terms:

Coronaviruses

Investigating the Consequences of Conjugated and Secreted ISG15 on Coronavirus Pathogenesis /
LDR:04252nam a22004333i 4500 001 391486
005 20251124054805.5
006 m o d
007 cr|nu||||||||
008 251208s2025 miu||||||m |||||||eng d
020 $a 9798315794851
035 $a (MiAaPQD)AAI31936874
035 $a AAI31936874
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Ali, Mudassir Syed, $e author. $3 524040
245 1 0 $a Investigating the Consequences of Conjugated and Secreted ISG15 on Coronavirus Pathogenesis / $c Mudassir Syed Ali.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (151 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
500 $a Advisors: Baker, Susan C. Committee members: Gallagher, Thomas; Knight, Katherine; Abbineni, Prabhodh; Choudhry, Mashkoor.
502 $b Ph.D. $c Loyola University Chicago $d 2025.
520 $a Coronaviruses have evolved a breadth of mechanisms to antagonize host innate immune responses. One widely studied mechanism is the ability to deconjugate ISG15 from target proteins in a process called deISGylation, which is catalyzed by the papain-like protease (PLP) domain of viral non-structural protein (nsp) 3. Since PLP activity is required for viral replication, it has been challenging to generate an infectious virus with a PLP that maintains protease activity but has lost deISGylase activity. In this study, we generated a chimeric MHV-A59 with its PLP2 domain replaced with that of the human coronavirus HKU1, which has been documented to have minimal deISGylase activity in vitro. By using this virus, we determined that the deISGylase activity is critical for inhibiting the IFN-response in primary macrophages and promoting robust viral replication. Importantly, we also report that without deISGylase activity, the chimeric virus is highly attenuated in vivo and is more rapidly cleared from infected mice compared to MHV-A59. Accordingly, we found that at earlier stages of infection, MHV-HP2 induces a higher IFN response in the liver, providing a potential mechanism for the rapid clearance of the deISGylase-deficient coronavirus. These results document the critical role of viral deISGylase activity as a key contributor to innate immune evasion during coronavirus infection.We also investigated the ability of ISG15 to be secreted from the cell in response to coronavirus infection. The mechanism of ISG15 secretion was unknown. Here, we report that ISG15 is secreted from inflammasome-activated macrophages via gasdermin D (GSDMD) pores on the plasma membrane, mirroring the unconventional secretory pathway used by IL-1β and IL-18. Secretion of ISG15 is negated by deletion of GSDMD. It is also inhibited by treatment with the small-molecule pan-caspase inhibitor zVAD-fmk, the FDA-approved drug disulfiram, the caspase-1 inhibitor VX-765, and the NLRP3 inhibitor MCC-950, all of which block GSDMD pore formation. This study paves the way for investigating how extracellular ISG15 contributes to viral pathogenesis.Finally, we interrogated the effects of extracellular ISG15 on coronavirus replication and activation of the innate immune response through the addition of recombinant ISG15 (rISG15) to macrophages. By analyzing changes in gene expression and cytokine release in BMDMs treated with rISG15 and comparing them to IFN-driven responses, we determined that extracellular ISG15 has antiviral and proinflammatory effects during MHV-infection that is distinct from the IFN response. This study contributes to our understanding of how coronavirus infection drives inflammation within the infected host.
546 $a English
590 $a School code: 0112
650 4 $a Cellular biology. $3 523871
650 4 $2 96060 $a Microbiology. $3 187154
650 4 $2 96060 $a Immunology. $3 187040
650 4 $2 96060 $a Virology. $3 187922
653 $a Coronaviruses
653 $a Non-structural protein
653 $a Papain-like protease
653 $a Pathogenesis
690 $a 0720
690 $a 0982
690 $a 0379
690 $a 0410
710 2 $a Loyola University Chicago. $b Microbiology and Immunology. $e degree granting institution. $3 524041
720 1 $a Baker, Susan C. $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-12B.
790 $a 0112
791 $a Ph.D.
792 $a 2025
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31936874